KBI Biopharma

Highly Engaged Employees

KBI Biopharma, founded in 1996, operates as a prominent contract development and manufacturing organization (CDMO) within the biopharmaceutical and manufacturing sectors. The company specializes in integrated drug development, process development, and commercialization services, providing end-to-end solutions for biological drug discovery and manufacturing. By leveraging advanced instrumentation and regulatory support, KBI Biopharma facilitates the transition of complex molecules from clinical stages to commercial production, serving a global client base with agile, science-driven methodologies.

With a workforce of 1,000-5,000 employees, the organization maintains a robust operational footprint across 3 strategic locations. This scale allows for comprehensive support in cell line development, testing, and manufacturing services. Meet KBI Biopharma's team to gain insights into the leadership and technical expertise driving their operational success. The company’s commitment to high-quality manufacturing standards ensures that they remain a critical partner for biopharmaceutical firms seeking to accelerate their drug development pipelines through reliable, expert-led contract services.

KBI Biopharma demonstrates significant market presence, competing with major industry players such as Catalent, Patheon Pharma Services, and FUJIFILM Biotechnologies. The company reported annual revenue of $592.1M, reflecting its established position in the competitive biopharmaceutical landscape. Explore financial highlights to review detailed metrics regarding their growth and funding history. Through continuous investment in integrated biopharmaceutical development and manufacturing facilities, KBI Biopharma remains dedicated to delivering life-changing outcomes for patients worldwide while maintaining a strong competitive edge in the global life sciences market.